US Stock MarketDetailed Quotes
DNLI Denali Therapeutics
- 25.000
- -0.160-0.64%
Close Nov 29 13:00 ET
- 25.000
- 0.0000.00%
Post 17:02 ET
3.60BMarket Cap-9057P/E (TTM)
25.420High24.810Low388.12KVolume25.100Open25.160Pre Close9.72MTurnover0.30%Turnover RatioLossP/E (Static)143.92MShares33.33052wk High2.73P/B3.25BFloat Cap14.56052wk Low--Dividend TTM130.11MShs Float93.940Historical High--Div YieldTTM2.42%Amplitude12.320Historical Low25.036Avg Price1Lot Size
Denali Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 204.74%330.53M | 0 | -64.40%1.27M | 460.45%294.12M | -16.61%35.14M | 122.90%108.46M | -17.83%10.28M |
| Operating revenue | --0 | --0 | --0 | 214.60%330.53M | --0 | 588.59%1.27M | 460.45%294.12M | -16.61%35.14M | 115.93%105.07M | -18.01%10.26M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 7.06%123.19M | -5.70%116.59M | -15.20%132.25M | 17.37%527.23M | 14.65%132.57M | 3.62%115.06M | 8.56%123.64M | 43.55%155.96M | 30.43%449.21M | 29.00%115.63M |
| Selling and administrative expenses | -1.48%24.95M | -3.55%25.19M | -7.02%25.24M | 14.23%103.35M | 5.33%24.77M | 8.88%25.33M | 23.45%26.12M | 20.40%27.14M | 14.44%90.48M | 8.07%23.52M |
| -General and administrative expense | -1.48%24.95M | -3.55%25.19M | -7.02%25.24M | 14.23%103.35M | 5.33%24.77M | 8.88%25.33M | 23.45%26.12M | 20.40%27.14M | 14.44%90.48M | 8.07%23.52M |
| Research and development costs | 9.47%98.24M | -6.28%91.4M | -16.92%107.02M | 18.16%423.88M | 17.04%107.8M | 2.22%89.74M | 5.16%97.52M | 49.62%128.82M | 35.19%358.73M | 35.70%92.11M |
| Operating profit | -8.25%-123.19M | -168.39%-116.59M | -9.47%-132.25M | 42.27%-196.7M | -25.85%-132.57M | -5.87%-113.8M | 377.59%170.48M | -81.68%-120.82M | -15.21%-340.74M | -36.60%-105.34M |
| Net non-operating interest income expense | 10.75%16M | 36.18%17.57M | 44.22%15.91M | 248.62%51.51M | 97.13%13.13M | 244.92%14.44M | 386.98%12.9M | 763.38%11.03M | 221.52%14.77M | 418.29%6.66M |
| Non-operating interest income | 10.75%16M | 36.18%17.57M | 44.22%15.91M | 248.62%51.51M | --13.13M | --14.44M | 386.98%12.9M | 763.38%11.03M | 221.52%14.77M | ---- |
| Other net income (expense) | 14.54M | |||||||||
| Special income (charges) | --0 | --0 | --14.54M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Gain on sale of business | --0 | --0 | --14.54M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Income before tax | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.46%-145.19M | -21.04%-119.44M | 3.82%-99.35M | 412.05%183.38M | -68.32%-109.78M | -11.96%-325.97M | -30.13%-98.68M |
| Income tax | 42.86%30K | 103.65%21K | 98.96%-6K | |||||||
| Net income | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M | -12.19%-325.99M | -31.11%-98.68M |
| Net income continuous Operations | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M | -12.19%-325.99M | -31.11%-98.68M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M | -12.19%-325.99M | -31.11%-98.68M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M | -12.19%-325.99M | -31.11%-98.68M |
| Basic earnings per share | 12.50%-0.63 | -144.03%-0.59 | 15.00%-0.68 | 59.23%-1.06 | -14.67%-0.86 | 14.29%-0.72 | 379.17%1.34 | -50.94%-0.8 | -8.79%-2.6 | -20.97%-0.75 |
| Diluted earnings per share | 12.50%-0.63 | -145.38%-0.59 | 15.00%-0.68 | 59.23%-1.06 | -14.67%-0.86 | 14.29%-0.72 | 370.83%1.3 | -50.94%-0.8 | -8.79%-2.6 | -20.97%-0.75 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data